Investor

Takeda Pharmaceutical

Last cheque observed Jan 2017. Silence since then is not evidence of inactivity: our sources miss unannounced rounds.

QuietInvestment firm

VentureGrowthSeries A

Cheques on record
0%of best year0cheques in 12 months, 8 on record
Since the last cheque3580days00hrs00min00sec
Median round$28MRounds led0 of 8Sole investor5 roundsMostly inUnited States, 75%
Pitch Takeda Pharmaceutical

Takeda Pharmaceutical highlights

  1. 01

    8 rounds on record

  2. 02

    Mostly Venture and Growth: 67% of its rounds

  3. 03

    Sole investor in 5 rounds, median $10M

What they do

Type
Investment firm (from a list, unverified)
Cheque size
Not stated
Cold pitches
Not stated

The record

Every round we can evidence, newest first8 appearances

  1. 2017

    1 round

  2. Jan
    PvP BiologicsUS · FinSMEs$35MSole investor
  3. 2016

    1 round

  4. Dec
    CerevanceSeries A · US · FinSMEs$22MWith 1 other
  5. 2015

    3 rounds

  6. Dec
    ProsettaSeries D · US$31MWith 1 other
  7. Oct
    UnivercellsVenture · BE$3.4MSole investor
  8. Sept
    Encycle TherapeuticsVenture · CA$2.1MWith 4 others
  9. 2014

    1 round

  10. Jan
    Seattle GeneticsUS$9.0MSole investor
  11. 2011

    1 round

  12. Mar
    Alnylam PharmaceuticalsVenture · US · masshightech.com$10MSole investor
  13. 2004

    1 round

  14. Oct
    BioNumerik PharmaceuticalsGrowth · US$52MSole investor

An announcement gives the size of the round, not the size of this investor's cheque: the only rounds that imply a cheque are those where they were the sole named investor.

Companies it bought

Acquisitions by the firm itself

InviragenUndisclosedMay 2013
LigoCyte Pharmaceuticals$60MOct 2012
Intellikine$310MDec 2011
Millennium Pharmaceuticals$8.7BFeb 2008
Takeda Bio Development CenterUndisclosedFeb 2008
Syrrx$270MFeb 2005

Recently backed

The latest companies Takeda Pharmaceutical put money into.

Cerevance$22M · Dec 2016

Mentioned on podcasts

Episodes that name Takeda Pharmaceutical in their description, not their title.

Quick answers about Takeda Pharmaceutical

What does Takeda Pharmaceutical invest in?

Takeda Pharmaceutical invests most often at Venture and Growth (67% of the rounds on record).

How active is Takeda Pharmaceutical?

8 investments on record, 0 of them in the last 12 months. The most recent was in Jan 2017.

What has Takeda Pharmaceutical invested in recently?

Its most recent investments on record: PvP Biologics (Undisclosed round, Jan 2017) and Cerevance (Series A, Dec 2016).

How big are Takeda Pharmaceutical's cheques?

The median round it joins is $28M.

Does Takeda Pharmaceutical lead rounds?

Rarely, if at all: none of its 8 investments on record names it as the lead.

Where does Takeda Pharmaceutical invest?

Most of the companies it backs are in the United States (75%), Belgium (13%) and Canada (13%).

Is Takeda Pharmaceutical investing now?

No investments in the last 12 months; the latest was in Jan 2017.

What kind of investor is Takeda Pharmaceutical?

Takeda Pharmaceutical is an investment firm.

Raising now?

Find the investors who back rounds like yours, and keep every conversation on one fundraising board.

Find similar investorsOpen your CRM

Built from the rounds we watched, its filings and its own website, refreshed every night. How we count · Report a correction · Is this your firm? Claim it